J Stehlik

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis
    J Stehlik
    Cardiology Section, University of Utah School of Medicine, VA Salt Lake City Health Care System, Salt Lake City, Utah 84148, USA
    J Heart Lung Transplant 25:1402-9. 2006
  2. ncbi request reprint Early screening for antibody-mediated rejection in heart transplant recipients
    Abdallah G Kfoury
    LDS Hospital and Intermountain Healthcare, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:1264-9. 2007
  3. doi request reprint ISHLT International Registry for Heart and Lung Transplantation - three decades of scientific contributions
    Josef Stehlik
    Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Transplant Rev (Orlando) 27:38-42. 2013
  4. pmc Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Omar Wever-Pinzon
    U T A H Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Circulation 127:452-62. 2013
  5. doi request reprint Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis
    Josef Stehlik
    Utah Transplant Affiliated Hospitals U T A H Cardiac Transplant Program, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 29:291-8. 2010
  6. doi request reprint Utility of virtual crossmatch in sensitized patients awaiting heart transplantation
    Josef Stehlik
    U T A H Cardiac Transplant Program, University of Utah Hospital, and VA Salt Lake City Health Care System Cardiology Section, 500 Foothill Blvd, Salt Lake City, UT 84148, USA
    J Heart Lung Transplant 28:1129-34. 2009
  7. doi request reprint Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure
    Josef Stehlik
    Cardiology Section, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA
    J Card Fail 15:31-4. 2009
  8. ncbi request reprint Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure
    Josef Stehlik
    University of Utah School of Medicine, Cardiology Section, VA Salt Lake City Healthcare System, 500 Foothill Boulevard, Salt Lake City, UT 84117, USA
    Expert Opin Investig Drugs 15:733-42. 2006
  9. doi request reprint Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy
    N M Heikal
    ARUP Institute for Clinical and Experimental Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Transplant Proc 45:376-82. 2013
  10. doi request reprint Impact of donor cause of death on transplant outcomes: UNOS registry analysis
    A K Singhal
    Department of Surgery, University of Utah, Salt Lake City, Utah, USA
    Transplant Proc 41:3539-44. 2009

Collaborators

Detail Information

Publications17

  1. ncbi request reprint Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis
    J Stehlik
    Cardiology Section, University of Utah School of Medicine, VA Salt Lake City Health Care System, Salt Lake City, Utah 84148, USA
    J Heart Lung Transplant 25:1402-9. 2006
    ..This study was undertaken to identify risk factors for late rejection and to examine the impact of different biopsy surveillance protocols on outcomes using the registry of the Cardiac Transplant Research Database...
  2. ncbi request reprint Early screening for antibody-mediated rejection in heart transplant recipients
    Abdallah G Kfoury
    LDS Hospital and Intermountain Healthcare, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:1264-9. 2007
    ..In this study, we examine whether a pattern of repetitive AMR occurred early enough after transplantation to warrant prospective immunohistochemistry screening in all recently transplanted recipients...
  3. doi request reprint ISHLT International Registry for Heart and Lung Transplantation - three decades of scientific contributions
    Josef Stehlik
    Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
    Transplant Rev (Orlando) 27:38-42. 2013
    ..This manuscript describes the logistics of the Registry's operations, its goals and future directions...
  4. pmc Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Omar Wever-Pinzon
    U T A H Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
    Circulation 127:452-62. 2013
    ..Survival of patients on left ventricular assist devices (LVADs) has improved. We examined the differences in risk of adverse outcomes between LVAD-supported and medically managed candidates on the heart transplant waiting list...
  5. doi request reprint Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis
    Josef Stehlik
    Utah Transplant Affiliated Hospitals U T A H Cardiac Transplant Program, Salt Lake City, Utah 84132, USA
    J Heart Lung Transplant 29:291-8. 2010
    ..Quantification of donor-associated risk in a specific heart transplant recipient is often difficult. Our aim was to identify donor characteristics that affect survival in the contemporary era...
  6. doi request reprint Utility of virtual crossmatch in sensitized patients awaiting heart transplantation
    Josef Stehlik
    U T A H Cardiac Transplant Program, University of Utah Hospital, and VA Salt Lake City Health Care System Cardiology Section, 500 Foothill Blvd, Salt Lake City, UT 84148, USA
    J Heart Lung Transplant 28:1129-34. 2009
    ..This study examined the accuracy of virtual crossmatch, in which recipient HLA-specific antibodies, identified by solid-phase assays, are compared to the prospective donor HLA-type in heart transplantation...
  7. doi request reprint Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure
    Josef Stehlik
    Cardiology Section, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA
    J Card Fail 15:31-4. 2009
    ..The use of additional vasodilators to further reduce pulmonary vascular resistance is often accompanied by unacceptable reductions in systemic arterial pressure...
  8. ncbi request reprint Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure
    Josef Stehlik
    University of Utah School of Medicine, Cardiology Section, VA Salt Lake City Healthcare System, 500 Foothill Boulevard, Salt Lake City, UT 84117, USA
    Expert Opin Investig Drugs 15:733-42. 2006
    ..Recent studies also suggest that PDE5 inhibitors may have antihypertropic effects, exerted through increased myocardial cGMP signalling, that could be of additional benefit in patients with heart failure...
  9. doi request reprint Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy
    N M Heikal
    ARUP Institute for Clinical and Experimental Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Transplant Proc 45:376-82. 2013
    ..The aim of this study was to evaluate the immune function and assess its utility in predicting rejection, CAV, and infection in heart transplantation recipients...
  10. doi request reprint Impact of donor cause of death on transplant outcomes: UNOS registry analysis
    A K Singhal
    Department of Surgery, University of Utah, Salt Lake City, Utah, USA
    Transplant Proc 41:3539-44. 2009
    ..In summary, this multi-institutional study confirms that DCOD is a modest predictor of survival and rejection of solid organ allografts of different types...
  11. pmc Impact of donor left ventricular hypertrophy on survival after heart transplant
    O Wever Pinzon
    UTAH Cardiac Transplant Program, University of Utah Health Sciences Center, Salt Lake City, UT, USA
    Am J Transplant 11:2755-61. 2011
    ..However, the use of allografts with LVH in association with other high-risk characteristics may result in increased mortality...
  12. doi request reprint Noninvasive diagnosis of cardiac allograft rejection using echocardiography indices of systolic and diastolic function
    F M Bader
    Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
    Transplant Proc 43:3877-81. 2011
    ..The purpose of our study was to evaluate various systolic and diastolic indices, including newer tissue Doppler imaging techniques, in diagnosing cardiac allograft rejection...
  13. doi request reprint Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection
    J R Kotter
    Utah Transplantation Affiliated Hospitals, University of Utah School of Medicine, Salt Lake City, 84132, USA
    Transplant Proc 42:2687-92. 2010
    ..Blood product transfusion has been successfully used in solid-organ transplantation to induce tolerance. Whether a similar protective effect of blood product transfusion exists in heart transplantation is controversial...
  14. pmc Ventricular assist devices: pharmacological aspects of a mechanical therapy
    O Wever-Pinzon
    Divisions of Cardiology and Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA
    Pharmacol Ther 134:189-99. 2012
    ..Areas of uncertainty and ground for future research are also highlighted...
  15. ncbi request reprint Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns
    Abdallah G Kfoury
    LDS Hospital, Intermountain Health Care, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 25:1277-82. 2006
    ..The current retrospective analysis was done to determine whether our previous criteria for pattern designations provided the greatest degree of discrimination between AMR and CR...
  16. ncbi request reprint Long-term outcomes of cardiac transplantation for peri-partum cardiomyopathy: a multiinstitutional analysis
    Kismet D Rasmusson
    UTAH Cardiac Transplant Program, LDS Hospital, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 26:1097-104. 2007
    ..Outcomes of patients with a prior diagnosis of peri-partum cardiomyopathy (PPCM) undergoing heart transplantation are not well described but may be worse than for women who undergo transplantation for other etiologies...
  17. ncbi request reprint Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies
    M Elizabeth H Hammond
    Department of Pathology, LDS Hospital, Salt Lake City, Utah 84143, USA
    J Heart Lung Transplant 24:2015-21. 2005
    ..The aim of this study was to determine whether VASC and ENDO are adequate to act as screening parameters to trigger further AMR investigation...